IMMUNOSTATUS OF UNTREATED CERVICAL-CARCINOMA

被引：11
作者：
ALSABTI, EAK [1 ]
机构：
[1] ALBAATH SPECIF PROT UNIT,BAGHDAD,IRAQ
来源：
GYNECOLOGIC ONCOLOGY | 1980年 / 9卷 / 01期
关键词：
D O I：
10.1016/0090-8258(80)90002-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6 / 11
页数：6
相关论文
共 30 条
[1]  
ALLISON AC, 1977, CANCER IMMUNOL IMMUN, V2, P151
[2]  
ALSABTI EAK, ONCOLOGY
[3]  
BOLTON PM, 1976, CANCER IMMUNOL IMMUN, V1, P251
[4]  
BURNET FM, 1967, LANCET, V1, P1171
[5]   PROGNOSTIC CORRELATIONS IN MALIGNANT-MELANOMA [J].
CLAUDY, AL ;
VIAC, J ;
PELLETIER, N ;
FOUADWASSEF, N ;
ALARIO, A ;
THIVOLET, J .
EUROPEAN JOURNAL OF CANCER, 1975, 11 (11) :821-827
[6]   SERUM LYSOZYME AS A MARKER OF HOST RESISTANCE .1. PRODUCTION BY MACROPHAGES RESIDENT IN RAT SARCOMATA [J].
CURRIE, GA ;
ECCLES, SA .
BRITISH JOURNAL OF CANCER, 1976, 33 (01) :51-59
[7]   SERUM LYSOZYME AS A MARKER OF HOST-RESISTANCE .2. PATIENTS WITH MALIGNANT-MELANOMA, HYPERNEPHROMA OR BREAST CARCINOMA [J].
CURRIE, GA .
BRITISH JOURNAL OF CANCER, 1976, 33 (06) :593-599
[8]  
EDWARDS AJ, 1977, CLIN ONCOL, V3, P65
[9]  
Eilber F R, 1970, Cancer, V25, P362, DOI 10.1002/1097-0142(197002)25:2<362::AID-CNCR2820250213>3.0.CO
[10]  
2-V
123